Innovation in Health and Care

/content/rand/randeurope/research/health/healthcare-industry/jcr:content/par/wrapperdiv_156735908/wrapperdiv_885432439/teaserlist

Featured initiative

• 

  Navigating and improving healthcare innovation, industry and policy

  RAND Europe helps decisionmakers navigate the changing societal, scientific and technological landscape to identify solutions that positively impact the health of populations and healthcare systems globally.

/content/rand/randeurope/research/health/healthcare-industry/jcr:content/par/wrapperdiv_156735908/wrapperdiv_885432439/teaserlist_0

Research, commentary, and events

• 

  Commentary

  Fintech's Role in Reducing Disparities and Financial Barriers to Health Care Access

  26 Jul 2021

  Given the growing pressures on health care systems globally and the need for innovative approaches to financing health care, the time may be ripe to develop a robust evidence base and share learning on fintech-enabled approaches that could support universal health coverage agendas and healthier and more stable societies.

• 

  Project

  Exploring the variation across countries in access to faecal microbiota transplantation

  25 Jun 2021

  RAND Europe has been commissioned by Ferring Pharmaceuticals to undertake an independent study that will explore current practice and differences in the establishment, running and distribution of stool banks and in the availability of FMT to patients with recurrent C. difficile infection, across a sample of geographies.

• 

  Project

  Addressing challenges in care for patients with Clostridioides difficile infection

  23 Jun 2021

  RAND Europe has been commissioned by Ferring Pharmaceuticals to undertake an independent study that aims to identify and characterise the challenges in the care pathway for patients with C. difficile infection and consider key areas for improvement in the care patients receive.

• 

  Multimedia

  Digital Technologies to Improve Health and Care

  18 Jun 2021

  John Campbell, professor of general practice and primary care at the University of Exeter, and Brandi Leach, senior analyst at RAND Europe, discuss how primary care practices can support patients' use of digital services.

• 

  Commentary

  Thinking Through Rapid and Scalable Rollout of Healthcare Innovations for Public Health Challenges

  14 Jun 2021

  The COVID-19 pandemic has shown that rapid innovation in the face of public health emergencies is possible. In only 15 months, 15 vaccines have been approved or authorized for use in various parts of the world. What thinking is required to support uniform rapid rollout for future public health emergencies?

• 

  Project

  Evaluating the progress and impacts of the COG-UK consortium

  16 Apr 2021

  The COVID-19 Genomics UK (COG-UK) consortium has commissioned RAND Europe to evaluate its progress and impact, to provide learning and insights that should be relevant for future efforts to link genomics research with public health decision-making needs.

• 

  Project

  Understanding industry contributions to the fight against antimicrobial resistance

  12 Feb 2021

  The AMR Industry Alliance brings together over 100 biotechnology, diagnostic, generics and research-based biopharmaceutical companies and trade associations in the fight against AMR. RAND Europe has been commissioned by the AMR Industry Alliance to assess the progress of its members in contributing to tackling AMR.

• 

  Project

  Understanding the financial ecosystem surrounding the development of medicines

  12 Feb 2021

  To enable governments to make more informed policy decisions that optimise value for their citizens, while at the same time appropriately reimbursing innovators, researchers are exploring the evidence base on how medicines R&D is financed and how this may evolve in the future.

• 

  Project

  Diagnosis, treatment and management of central diabetes insipidus

  15 Jan 2021

  RAND Europe was commissioned by Ferring Pharmaceuticals to look at care pathways for patients with CDI. The research focuses on identifying the factors that influence the diagnosis, treatment and management of patients with CDI, as well as areas to consider that may improve the quality of care that patients receive, and patient outcomes.

• 

  Multimedia

  Sustainable Pharmaceutical Innovation for COVID-19 and Other Infectious Diseases

  16 Sep 2020

  RAND Europe's Sonja Marjanovic describes the critical success criteria for innovation in infectious disease, antimicrobial, and vaccine research and development.

• 

  Multimedia

  The Future of the Pharmaceutical Industry

  08 Sep 2020

  RAND Europe's Sonja Marjanovic explains how changes in society have brought about opportunities for the pharmaceutical industry to innovate to better meet the needs of patients and health care systems.

• 

  Commentary

  How to best enable pharma innovation beyond the COVID-19 crisis

  26 May 2020

  Innovating in response to public health challenges like COVID-19 does not always align well with pharmaceutical industry commercial models or shareholder expectations. More sustainable and scalable ways of incentivising innovation in response to infectious disease threats are needed.

• 

  Commentary

  The Pandemic Has Sparked Innovation, Offering Lessons We Must Not Forget

  01 Apr 2020

  COVID-19 has shocked the world and caught most countries unprepared, forcing them to improvise. But amid all the confusion and fear, the power of individuals, organizations, and communities to think differently and to innovate shows what can be achieved when people are united by common, clear priorities and necessity.

• 

  Project

  Assessing the use of new technologies for infectious disease surveillance, prevention and control

  14 Jan 2020

  RAND Europe is providing research and support for the European Centre for Disease Prevention and Control (ECDC) for the assessment of new technologies for infectious disease surveillance, prevention and control over the next two years.

• 

  Project

  Assessing EHR for infectious disease surveillance, prevention and control

  02 Dec 2019

  Electronic health records (EHR) data could greatly help infectious disease surveillance, but their use varies across Europe. Researchers are mapping EHR use to assess the feasibility of using EHR data for infectious disease surveillance.

• Page 1 of 4
• 1
• 2
• 3
• 4
• Next